Literature DB >> 18439911

Ablation of estrogen receptor alpha (ERalpha) prevents upregulation of POMC by leptin and insulin.

Michi Hirosawa1, Mutsuko Minata, Kouji H Harada, Toshiaki Hitomi, Andree Krust, Akio Koizumi.   

Abstract

Diabetic Akita male mice are more hyperphagic because of downregulation of proopiomelanocortin (POMC) caused by hypoleptinemia. We investigated the role of estrogen receptor alpha (ERalpha) in the regulation of the hypothalamic POMC in females. ERaKOAkt mice consumed 30% greater food (g/3 weeks) than the Akita diabetic controls. Ovariectomized diabetic (AFO) and nondiabetic (B6FO) mice had significantly lower food intake and elevated serum leptin levels. ERaKOAkt and ERaKO mice also increased serum leptin concentrations, while hypoinsulinemia was observed in ERaKOAkt and hyperinsulinemia in ERaKO mice. RT-PCR showed a significant attenuation of POMC expression in both ERaKOAkt and ERaKO mice, irrespective of the elevated leptin serum levels or hyperinsulinemia, while elevated serum leptin levels in AFO and B6FO mice upregulated POMC gene expression. These results indicate that ERalpha plays an essential role in leptin- and insulin-stimulated upregulation of the POMC gene. This action of ERalpha is likely mediated in a ligand-independent manner.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18439911     DOI: 10.1016/j.bbrc.2008.04.073

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

Review 1.  Impaired estrogen receptor action in the pathogenesis of the metabolic syndrome.

Authors:  Andrea L Hevener; Deborah J Clegg; Franck Mauvais-Jarvis
Journal:  Mol Cell Endocrinol       Date:  2015-05-29       Impact factor: 4.102

Review 2.  Estradiol signaling in the regulation of reproduction and energy balance.

Authors:  Kevin Sinchak; Edward J Wagner
Journal:  Front Neuroendocrinol       Date:  2012-09-07       Impact factor: 8.606

Review 3.  Metabolic impact of sex hormones on obesity.

Authors:  Lynda M Brown; Lana Gent; Kathryn Davis; Deborah J Clegg
Journal:  Brain Res       Date:  2010-05-23       Impact factor: 3.252

Review 4.  Interacting Neural Processes of Feeding, Hyperactivity, Stress, Reward, and the Utility of the Activity-Based Anorexia Model of Anorexia Nervosa.

Authors:  Rachel A Ross; Yael Mandelblat-Cerf; Anne M J Verstegen
Journal:  Harv Rev Psychiatry       Date:  2016 Nov/Dec       Impact factor: 3.732

5.  Estrogen response element-independent signaling partially restores post-ovariectomy body weight gain but is not sufficient for 17β-estradiol's control of energy homeostasis.

Authors:  Kyle J Mamounis; Jennifer A Yang; Ali Yasrebi; Troy A Roepke
Journal:  Steroids       Date:  2013-11-16       Impact factor: 2.668

Review 6.  Importance of oestrogen receptors to preserve functional β-cell mass in diabetes.

Authors:  Joseph P Tiano; Franck Mauvais-Jarvis
Journal:  Nat Rev Endocrinol       Date:  2012-02-14       Impact factor: 43.330

7.  Leptin receptor (Lepr) is a negative modulator of bone mechanosensitivity and genetic variations in Lepr may contribute to the differential osteogenic response to mechanical stimulation in the C57BL/6J and C3H/HeJ pair of mouse strains.

Authors:  Sonia Kapur; Mehran Amoui; Chandrasekhar Kesavan; Xiaoguang Wang; Subburaman Mohan; David J Baylink; K-H William Lau
Journal:  J Biol Chem       Date:  2010-09-17       Impact factor: 5.157

Review 8.  Minireview: Estrogenic protection of beta-cell failure in metabolic diseases.

Authors:  Suhuan Liu; Franck Mauvais-Jarvis
Journal:  Endocrinology       Date:  2009-12-04       Impact factor: 4.736

Review 9.  Energy metabolism and fertility: a balance preserved for female health.

Authors:  Sara Della Torre; Valeria Benedusi; Roberta Fontana; Adriana Maggi
Journal:  Nat Rev Endocrinol       Date:  2013-10-22       Impact factor: 43.330

Review 10.  The role of estrogens in control of energy balance and glucose homeostasis.

Authors:  Franck Mauvais-Jarvis; Deborah J Clegg; Andrea L Hevener
Journal:  Endocr Rev       Date:  2013-03-04       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.